Guidance
← Earnings Calls
01
02
03
04 05 06
Tone
A1 A2 A3 A4
CTVA
FY2026 Q1
Improving
Corteva, Inc. earnings call
Buzzberg read
Corteva reaffirms full-year guidance with strong Q1 EBITDA growth
Corteva delivered a strong Q1 2026, with EBITDA up 21% driven by seed timing and crop protection volume gains. Management maintained full-year guidance, signaling the first half is tracking better than expected, and progressed on its separation plan, naming the new seed company 'Vylor'. Q1 2026 operating EBITDA up 21% to over $1.4 billion, with organic sales up 7%.
Buzzberg read Corteva reaffirms full-year guidance with strong Q1 EBITDA growth Corteva delivered a strong Q1 2026, with EBITDA up 21% driven by seed timing and crop protection volume gains. Management maintained full-year guidance, signaling the first half is tracking better than expected, and progressed on its separation plan, naming the new seed company 'Vylor'. Q1 2026 operating EBITDA up 21% to over $1.4 billion, with organic sales up 7%. Read full analysisCollapse analysis
Corteva delivered a strong Q1 2026, with EBITDA up 21% driven by seed timing and crop protection volume gains. Management maintained full-year guidance, signaling the first half is tracking better than expected, and progressed on its separation plan, naming the new seed company 'Vylor'. Q1 2026 operating EBITDA up 21% to over $1.4 billion, with organic sales up 7%.
- Management reiterated FY2026 guidance of $4.0-4.2B EBITDA and $3.45-3.70 EPS.
- The company is ahead of schedule on its path to becoming royalty positive in 2026, a fulyear earlier than originally planned.
- Corteva announced the name 'Vylor' for its future seed and genetics spin-off, with a Q4 separation still on track.
Revenue$4.905B+25% QoQ
EPS$1.50Reported
Gross margin51.64%Reported
Operating margin23.55%Reported
6 grounded callouts
What matters now
The highest-signal changes from the call.
Margins
First quarter operating EBITDA up 21%, margin expands 240 basis points
Seed
Seed business to become royalty positive later this year
Show 3 more callouts
Seed
Enlist soybean technology to cover 65% of U.S. acres
Separation
Separation on track for Q4, new companies named
Macro
Oil price spike adds $40 million headwind, tariffs favorable
Reported period
Actuals
| Metric | Reported | Change |
|---|---|---|
| Revenue | $4.905B | +25% QoQ |
| EPS | $1.50 | Reported |
| Gross margin | 51.64% | Reported |
| Operating margin | 23.55% | Reported |
| Free cash flow | $-2.972B | Reported |
| Capex | $0.081B | Reported |
Forward-looking
Forward guidance
| Metric | Period | Range | Midpoint | Status |
|---|---|---|---|---|
| EPS | FY2026 | $3.45–$3.70In line with consensus | $3.58 | Maintained |
AI, capex & demand read
Management read
Confident
Management expressed confidence in strong first-quarter results, reaffirmed guidance, and highlighted progress on strategic initiatives like the separation and royalty-positive milestone.
all 6 named companies below
Companiesreturns since call
Partners
Partners
Judd O'Connor
Corteva's biofuels program with Bunge and Chevron is progressing well, with good yields and high farmer retention, indicating a strong new revenue stream.
Evidence
“focused with bungie and Chevron, sustainable aviation fuel. The crop looks good agronomically. Yields look like they're going to be in a favorable position.”
Partners
Judd O'Connor
Corteva's 50-50 JV with BP is expanding its cover crop/mustard program in Latin America for biofuels, indicating significant growth potential in the region.
Evidence
“don't know that maybe you've seen the most recent estimate we've had with our JV, 50-50 JV with BP in Latin America, expanding mustard crops in Latin America”
Partners
Chuck Magro
The Bayer licensing agreement is driving stronger-than-expected demand for Corteva's seed technology, positioning the company to become royalty positive ahead of schedule.
Evidence
“with the Bayer agreement that we signed back in February, we're seeing just very strong demand for our corn and soybean technology.”
Competitors
Competitors
Chuck Magro
Competitive positioning in the ag industry is shifting, with Corteva's performance standing out, signaling potential share gains versus peers like Syngenta.
Evidence
“between yourself, you know, Syngenta, BASF. And the numbers, you know, have kind of spoken for themselves thus far.”
External signals
Supply-chain alpha · 4returns since call
Management stated the company will become 'royalty positive' later this year, a full year ahead of its original target, driven by its licensing model (100+ licensees) and the Bayer agreement.
Evidence
“Crossing the milestone of royalty neutrality into royalty positive later this year is a monumental accomplishment... This is the first year that we're going to be royalty positive. That's new information for this morning.”
Energy prices are rising in China and India, causing higher AI production costs and a slowdown in Chinese exports into Brazil. This is a potential inflection point for the global generic crop protection pricing environment.
Evidence
“With higher energy and oil pricing around the world now, that is adding cost inflation to AI production in the low production jurisdictions around the world, namely India and China. And so we are seeing price increases actually for certain…”
Corteva's biofuels program has achieved a 90%+ farmer retention rate, and the JV with BP in Latin America will start planting material crops in 2027, signaling a fast-moving commercial ramp for its next-gen crop program.
Evidence
“With that program or retention rate with the farmers that have dove in and taken on this new cropping system has been over 90%... We're going to expand somewhere north of 400,000 acres next year.”
Corteva expects first-half operating EBITDA to grow more than 7% year-over-year due to an early North American season and timing shifts, with the first half now expected to outperform the second half.
Methodology & coverage
Management-only analysis. All 6 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.